Trials / Completed
CompletedNCT04126486
A Study to Determine if Identification of Undiagnosed Atrial Fibrillation in People at Least 70 Years of Age Reduces the Risk of Stroke
GUARD-AF: reducinG Stroke by Screening for UndiAgnosed atRial Fibrillation in Elderly inDividuals
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 11,931 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if an AF detection intervention in men and women at least 70 years of age with undiagnosed atrial fibrillation (AF) or atrial flutter (AFL) reduces the person-years incidence rate of stroke compared to usual care (no AF detection intervention).
Detailed description
This a prospective, randomized study in primary care practices.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Zio®XT Monitor | A Zio® XT monitor will be affixed to the participant's chest |
Timeline
- Start date
- 2019-12-17
- Primary completion
- 2023-06-30
- Completion
- 2023-06-30
- First posted
- 2019-10-15
- Last updated
- 2023-07-12
Locations
176 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04126486. Inclusion in this directory is not an endorsement.